Position in NVS
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,027,396
+$100,083 QoQ
Shares Held
6,726
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Anchor Investment Management, LLC holds $69,112,010 across 15 Drug Manufacturers - General names. NVS ranks #8 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,612 | $21,415,877 | |
| 2 | ABBV |
AbbVie Inc.
|
87,821 | $19,100,189 | |
| 3 | LLY |
ELI LILLY & Co
|
13,180 | $12,122,568 | |
| 4 | MRK |
Merck & Co., Inc.
|
65,472 | $7,875,626 | |
| 5 | PFE |
Pfizer Inc
|
87,568 | $2,458,909 | |
| 6 | GSK |
GSK plc
|
33,440 | $1,845,553 | |
| 7 | AMGN |
Amgen Inc
|
4,884 | $1,718,435 | |
| 8 | NVS |
Novartis AG
This page
|
6,726 | $1,027,396 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,027,396 | 6,726 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $927,313 | 6,726 | Shares | Sole | 2026-02-26 | |
| 2025-09-30 | $862,542 | 6,726 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $838,115 | 6,926 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $783,258 | 7,026 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $732,355 | 7,526 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $865,640 | 7,526 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $809,202 | 7,601 | Shares | Sole | 2024-09-20 | |
| 2024-03-31 | $744,917 | 7,701 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $775,853 | 7,684 | Shares | Sole | 2024-01-02 | |
| 2023-09-30 | $782,692 | 7,684 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $795,574 | 7,884 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $725,328 | 7,884 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $715,236 | 7,884 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $622,065 | 8,184 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $725,605 | 8,584 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $753,246 | 8,584 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $750,842 | 8,584 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $674,685 | 8,250 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $804,280 | 8,815 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $779,150 | 9,115 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $860,729 | 9,115 | Shares | Sole | 2024-01-02 | |
| 2020-09-30 | $810,032 | 9,315 | Shares | Sole | 2024-01-02 | |
| 2020-06-30 | $825,799 | 9,455 | Shares | Sole | 2024-01-02 | |
| 2020-03-31 | $793,993 | 9,630 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||